Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 5, 2006International data suggests low revascularization rates for both TAXUS stent and PROMUS™ (XIENCE™ V) stent
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Abbott's SPIRIT II clinical trial, which reaffirmed...
-
Sep 1, 2006PROMUS Stent joins market-leading TAXUS® Paclitaxel-Eluting Coronary Stent Systems
Boston Scientific Corporation (NYSE: BSX) today announced plans for the anticipated International launch of its PROMUS™(1) Everolimus-Eluting...
-
Aug 31, 2006Results expected to continue to support safety and performance of Boston Scientific's second-generation drug-eluting stent system
Boston Scientific Corporation (NYSE: BSX) announced today that enrollment has exceeded 13,000 patients in the TAXUS OLYMPIA registry, designed to...
-
Aug 30, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Aug 23, 2006
ACME, Inc. has named Charlie Young senior vice president of marketing. Young comes to the company with more than 18 years of marketing experience. Young will oversee and direct the company's...
-
Jul 27, 2006
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2006. Highlights: - Acquisition...
-
Jul 26, 2006Precision™ SCS System, the first and smallest rechargeable system, achieves rapid adoption
Boston Scientific Corporation (NYSE: BSX) announced today that 5,000 patients with severe chronic pain have now been treated with the Precision™...
-
Jul 24, 2006Initial six-month results consistent with previous TAXUS registries
Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from Phase I of its global...
-
Jul 14, 2006New system enhances diagnosis and treatment of blocked vessels and heart disorders
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its iLab™ Ultrasound Imaging System. Intravascular ultrasound (IVUS)...
-
Jul 12, 2006New Jaw Configuration Designed to Yield Larger Tissue Specimens and Improve Procedural Outcomes
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of the newest version of its Radial Jaw® Single-Use Biopsy Forceps,...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that William E. Young has been appointed Vice President of Quality Assurance and...
-
Jul 10, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2006...
-
Jun 28, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a report from UBS Investment Research that ranked the Company number one in...
-
Jun 26, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it is providing safety information and retrieving a specific subset of pacemakers,...
-
Jun 23, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies Life Sciences Conference, which is being held June 27 - 28...
-
Jun 15, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding a July 2005 jury verdict in...
-
Jun 12, 2006Boston Scientific's TAXUS stent system used in more complex lesions than J&J's Cypher
Boston Scientific Corporation (NYSE: BSX) welcomed results from the independent, multi-center STENT registry, the largest prospective, comparative...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June...
-
Jun 9, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $1.2 billion aggregate principal amount of its...
-
Jun 6, 2006
Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $1.2 billion aggregate principal amount of its senior...
-
Jun 6, 2006Technology Features Powerful Combination of Deliverability and Trackability to Enhance Clinical Versatility
Boston Scientific Corporation (NYSE: BSX) today announced that it has received FDA clearance to launch its Sterling™ Monorail® and Over-the-Wire...
-
May 31, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market...
-
May 26, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that the Court of Appeals for the Federal Circuit has issued a ruling upholding a trial...
-
May 22, 2006Researchers say novel visualization capability may reduce common need for repeat procedures
Boston Scientific Corporation (NYSE: BSX) today announced favorable results from an investigator initiated first human use...
-
May 20, 2006Trial Advances Understanding of Dual-chamber Pacing for Patients at Risk of Sudden Cardiac Death
Boston Scientific Corporation (NYSE: BSX) today reported that the INTRINSIC RV investigative team presented results of a clinical trial designed to...